Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
The Quiet Race Reshaping Psychedelic Medicine [Meditech Today]
December 3, 2025
Healing A Broken Mental Health System: Dr Joseph Tucker of Enveric Biosciences On 5 Things That Can Be Done To Fix Our Broken Mental Health System [Medium]
December 1, 2025
Delix Therapeutics Reports Strong Phase Ib Results [Microdose]
November 26, 2025
Enveric Hires Fish & Richardson To Defend IP Against Petition Claiming Its Patent Contains Claims Relevant To AbbVie’s $1.2B Bretisilocin Acquisition [Benzinga]
October 15, 2025
AbbVie Could Face Patent Battle Over Depression Asset Gained in Gilgamesh Deal [SeekingAlpha]
October 15, 2025
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch [Microdose]
October 15, 2025
Enveric Biosciences Hires Fish & Richardson to Defend Patent Tied to AbbVie Deal [Investing.com]
October 15, 2025
After the Billion-Dollar Psychedelic Bet: Who’s Next for Big Pharma? [Microdose]
October 10, 2025
How Enveric Biosciences Is Prepping For Its First IND [Clinical Leader]
October 10, 2025
The Next Chapter in Psychedelic Medicine: How Enveric Biosciences Stands Apart [HoneySuckle]
September 22, 2025
1
2
3
…
15
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
